Sign in Subscribe
Cancer research

Cytokine-Based Immunotherapy for Gastric Cancer: A Promising Approach

Strategic Insights

— 2 min read

Cytokine-based immunotherapies have shown promise in treating gastric cancer, a type of cancer that affects the stomach lining. Researchers at the Saveetha School of Engineering in Tamil Nadu, India, have been studying the effects of cytokines on the immune system and their potential to combat cancer cells. The study, published in the journal Exploration of Targeted Anti-tumor Therapy, examined the relationship between cytokines and the tumor microenvironment (TME), revealing the role of immunosuppressive cytokines like IL-10 and transforming growth factor-beta (TGF-b) in promoting an immune-evasive phenotype.

Key Takeaways:

  • Cytokine-based immunotherapies can modify the immune system's inflammatory reactions to tumor cells, potentially slowing gastric cancer progression.
  • Pro-inflammatory cytokines can encourage tumor development, while antitumor cytokines can help the host reject cancer cells.
  • Researchers aim to renew immune cells like cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells by delivering cytokines like interleukin-2 (IL-2), interferons (IFNs), and tumor necrosis factor-alpha (TNF-a) to activate inflammatory pathways and combat tumors.
  • Cytokine-targeted methods for gastric cancer pro-inflammatory and antitumor immune responses are being explored.
  • Synthetic cytokines, cytokine-conjugates, and local administration of these are being developed to enhance the therapeutic index and minimize off-target damage.
  • The study suggests that inhibitory pathway targeting, and cytokine-based therapy may overcome resistance mechanisms.
  • Cytokine-based immunotherapies combined with immune checkpoint inhibitors are predicted to change gastric cancer therapy and rebuild tumor-immune microenvironment dynamics, restoring antitumor immunity.

Statistics:

  • Gastric cancer is a type of cancer affecting the stomach lining.
  • Cytokines play a significant role in the immune system's inflammatory reactions to tumor cells.
  • Pro-inflammatory cytokines can encourage tumor development, while antitumor cytokines can help the host reject cancer cells.
  • Researchers have identified 17 different types of cytokines involved in the immune system's response to cancer.
  • The study found that IL-10 and TGF-b were the most immunosuppressive cytokines in the tumor microenvironment.
  • Current clinical studies are being used to establish the position of cytokine-based therapy in gastric cancer treatment.

Sources:

  • Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control. Exploration of Targeted Anti-tumor Therapy, 2025,6():1002312.
  • Saveetha School of Engineering, Department of Biotechnology, Saveetha Institute of Medical and Technical Sciences, Chennai 602105, Tamil Nadu, India.
  • NewsRx. Study Results from Saveetha School of Engineering Update Understanding of Gastric Cancer (Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control). Immunotherapy Weekly. May 14, 2025; p 7705.

Read more